Concepedia

Author

Yanyong Xu

Northeast Ohio Medical UniversityORCID

Also Known As

Yan-Yong Xu, Yanyong Xu

54

Publications

1.3K

Citations

21

H-Index

37

Concepts

All Affiliations

Northeast Ohio Medical UniversityWuhan UniversityFudan UniversityUniversity of South CarolinaChinese Academy of Sciences
YX

About

Yanyong Xu is an author at Northeast Ohio Medical University specializing in medicine, metabolic syndrome, and metabolism.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

319

2

Health Sciences

6

6

227

3

Biochemistry

6

6

147

4

Cell Biology

5

5

170

5

Diabetes

1

1

27

Yanyong Xu

×

31

Publications

1.1K

Citations

21

H-Index

YearCitations

Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis

Yanyong Xu, Yang Xu, Yingdong Zhu,

Molecular Therapy

2019

121

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR

Kavita Jadhav, Yang Xu, Yanyong Xu,

Molecular Metabolism

2018

114

Hepatocyte Nuclear Factor 4α Prevents the Steatosis‐to‐NASH Progression by Regulating p53 and Bile Acid Signaling (in mice)

Yanyong Xu, Yingdong Zhu, Shuwei Hu,

Hepatology

2020

81

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

Yanyong Xu, Yuanyuan Li, Kavita Jadhav,

Nature Metabolism

2021

81

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease

Yanyong Xu, Yingdong Zhu, Shuwei Hu,

Molecular Metabolism

2021

71

Narirutin activates TFEB (transcription factor EB) to protect against Acetaminophen-induced liver injury by targeting PPP3/calcineurin

Zhiyuan Fang, Yanyong Xu, Guowen Liu,

Autophagy

2023

56

FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity

Xuguang Yang, Bo Deng, Weiwei Zhao,

Journal of Hepatology

2024

54

Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C/EBPα-SIRT1 pathway

Shuwei Hu, Liping Xia, Hanwen Luo,

Toxicology

2019

53

Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α

Yanyong Xu, Shuwei Hu, Kavita Jadhav,

Diabetes

2021

35

Lipocalin‐2 Protects Against Diet‐Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes

Yanyong Xu, Yingdong Zhu, Kavita Jadhav,

Hepatology Communications

2019

34

Page 1